Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Oct 26:02537176251388365.
doi: 10.1177/02537176251388365. Online ahead of print.

Clozapine-associated Weight Loss: A Case Series

Janani Rajasekaran  1 , Abhiram Purohith Narasimhan  1 , Rajeshkrishna P Bhandary  1 , Psvn Sharma  1
Affiliations

Clozapine-associated Weight Loss: A Case Series

Janani Rajasekaran et al. Indian J Psychol Med. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

References

    1. Samara MT, Nikolakopoulou A, Salanti G, et al. How many patients with schizophrenia do not respond to antipsychotic drugs in the short term? An analysis based on individual patient data from randomized controlled trials. Schizophr Bull, 2019; 45(3): 639–646. - PMC - PubMed
    1. de Bartolomeis A, Ciccarelli M, Vellucci L, et al. Update on novel antipsychotics and pharmacological strategies for treatment-resistant schizophrenia. Expert Opin Pharmacother, 2022; 23(18): 2035–2052. - PubMed
    1. Verdoux H, Quiles C, Bachmann CJ, et al. Prescriber and institutional barriers and facilitators of clozapine use: A systematic review. Schizophr Res, 2018; 201: 10–19. - PubMed
    1. Pillinger T, McCutcheon RA, Vano L, et al. Comparative effects of 18 antipsychotics on metabolic function in patients with schizophrenia, predictors of metabolic dysregulation, and association with psychopathology: A systematic review and network meta-analysis. Lancet Psychiat, 2020; 7(1): 64–77. - PMC - PubMed
    1. Rummel-Kluge C, Komossa K, Schwarz S, et al. Head-to-head comparisons of metabolic side effects of second-generation antipsychotics in the treatment of schizophrenia: A systematic review and meta-analysis. Schizophr Res, 2010; 123(2–3): 225–233. - PMC - PubMed

LinkOut - more resources